Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Eduardo Rivera‐Mancilla"'
Autor:
Anna K. Szewczyk, Samiye Ulutas, Tülin Aktürk, Linda Al-Hassany, Corinna Börner, Federica Cernigliaro, Michalis Kodounis, Salvatore Lo Cascio, David Mikolajek, Dilara Onan, Chiara Ragaglini, Susanna Ratti, Eduardo Rivera-Mancilla, Sofia Tsanoula, Rafael Villino, Karl Messlinger, Antoinette Maassen Van Den Brink, Tessa de Vries, on behalf of the European Headache Federation School of Advanced Studies (EHF-SAS)
Publikováno v:
The Journal of Headache and Pain, Vol 24, Iss 1, Pp 1-26 (2023)
Abstract Migraine is a severe neurovascular disorder of which the pathophysiology is not yet fully understood. Besides the role of inflammatory mediators that interact with the trigeminovascular system, cyclic fluctuations in sex steroid hormones are
Externí odkaz:
https://doaj.org/article/800eed8f73924606a2775bdd8d3111ba
Autor:
Eduardo Rivera-Mancilla, Linda Al-Hassany, Heleen Marynissen, Dorien Bamps, Ingrid M. Garrelds, Jérôme Cornette, A. H. Jan Danser, Carlos M. Villalón, Jan N. de Hoon, Antoinette MaassenVanDenBrink
Publikováno v:
Pharmaceuticals, Vol 17, Iss 2, p 156 (2024)
Transient receptor potential (TRP) channels are pivotal in modulating vascular functions. In fact, topical application of cinnamaldehyde or capsaicin (TRPA1 and TRPV1 channel agonists, respectively) induces “local” changes in blood flow by releas
Externí odkaz:
https://doaj.org/article/6da861e0a7624ecc9eac267bb8c3cd87
Autor:
Matteo Castaldo, Marta Waliszewska-Prosół, Maria Koutsokera, Micaela Robotti, Marcin Straburzyński, Loukia Apostolakopoulou, Mariarita Capizzi, Oneda Çibuku, Fidel Dominique Festin Ambat, Ilaria Frattale, Zukhra Gadzhieva, Erica Gallo, Anna Gryglas-Dworak, Gleni Halili, Asel Jusupova, Yana Koperskaya, Alo-Rainer Leheste, Maria Laura Manzo, Andrea Marcinnò, Antonio Marino, Petr Mikulenka, Bee Eng Ong, Burcu Polat, Zvonimir Popovic, Eduardo Rivera-Mancilla, Adina Maria Roceanu, Eleonora Rollo, Marina Romozzi, Claudia Ruscitto, Fabrizio Scotto di Clemente, Sebastian Strauss, Valentina Taranta, Maria Terhart, Iryna Tychenko, Simone Vigneri, Blazej Misiak, Paolo Martelletti, Alberto Raggi, On behalf of the European Headache Federation School of Advanced Studies (EHF-SAS)
Publikováno v:
The Journal of Headache and Pain, Vol 23, Iss 1, Pp 1-16 (2022)
Abstract Background Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are used to reduce the risk of developing Coronavirus Disease 2019 (COVID-19). Despite the significant benefits in terms of reduced risk of hospitalizat
Externí odkaz:
https://doaj.org/article/fe227dbef0c04045803b3508f3bc6b6f
Publikováno v:
Frontiers in Neurology, Vol 12 (2021)
Migraine is a disabling neurovascular disorder, characterized by moderate to severe unilateral headaches, nausea, photophobia, and/or phonophobia, with a higher prevalence in women than in men, which can drastically affect the quality of life of migr
Externí odkaz:
https://doaj.org/article/79d4de4cf7fb430d90ecf96d0ffa37f6
Autor:
Eduardo Rivera-Mancilla, Victor H. Avilés-Rosas, Guadalupe Manrique-Maldonado, Alain H. Altamirano-Espinoza, Belinda Villanueva-Castillo, Antoinette MaassenVanDenBrink, Carlos M. Villalón
Publikováno v:
The Journal of Headache and Pain, Vol 18, Iss 1, Pp 1-12 (2017)
Abstract Background Dihydroergotamine (DHE) is an acute antimigraine agent that displays affinity for dopamine D2-like receptors, serotonin 5-HT1/2 receptors and α1/α2-adrenoceptors. Since activation of vascular α1/α2-adrenoceptors results in sys
Externí odkaz:
https://doaj.org/article/4d842091c6ed4def9ddb5e122c8662c1
Autor:
Eduardo Rivera‐Mancilla, Alain H. Altamirano‐Espinoza, Guadalupe Manrique‐Maldonado, Belinda Villanueva‐Castillo, Carlos M. Villalón
Publikováno v:
Basic & Clinical Pharmacology & Toxicology. 131:262-269
Autor:
Eduardo, Rivera-Mancilla, Belinda, Villanueva-Castillo, Alain H, Altamirano-Espinoza, Guadalupe, Manrique-Maldonado, Carlos M, Villalón
Publikováno v:
European journal of pharmacology. 929
Abnormalities in the cardiac sympathetic innervation and tone, as well as in the noradrenergic system are associated, among other peripheral complications, with diabetes mellitus. Furthermore, B-HT 933, an agonist at α
Publikováno v:
Expert Opinion on Drug Safety, 19(10), 1237-1250. Taylor & Francis Ltd
Introduction: Since calcitonin gene-related peptide (CGRP) plays an important role in the pathophysiology of migraine via the activation of the trigeminovascular system, the newest prophylactic treatments directly block CGRP or its receptor. However,
Publikováno v:
Novel Synthetic Drugs in Migraine ISBN: 9783030953331
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ff60028db6c6ac8b9f127e6ab475a05
https://doi.org/10.1007/978-3-030-95334-8_1
https://doi.org/10.1007/978-3-030-95334-8_1
Autor:
Oswaldo Hernández-Abreu, Carlos M. Villalón, Belinda Villanueva-Castillo, Eduardo Rivera-Mancilla, Guadalupe Manrique-Maldonado, Asunción Morán, José Á. García‐Pedraza, Alain H. Altamirano-Espinoza, Mónica García-Domingo
Publikováno v:
Clinical and Experimental Pharmacology and Physiology. 47:403-411
Our group has previously shown in pithed rats that the cardiac sympathetic drive, which produces tachycardic responses, is inhibited by 5-HT via the activation of prejunctional 5-HT1B/1D/5 receptors. Interestingly, when 5-HT2 receptors are chronicall